Back
Clean Energy Fuels 10K Form
Sell
41
CLNE
Clean Energy Fuels
Last Price:
2.92
Seasonality Move:
6.27%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-05-09 | 10Q | CLNE/Clean Energy Fuels Quarterly |
2024-02-29 | 10K | CLNE/Clean Energy Fuels Annual |
2023-11-09 | 10Q | CLNE/Clean Energy Fuels Quarterly |
2023-08-09 | 10Q | CLNE/Clean Energy Fuels Quarterly |
2023-05-09 | 10Q | CLNE/Clean Energy Fuels Quarterly |
2023-02-28 | 10K | CLNE/Clean Energy Fuels Annual |
Receive CLNE News And Ratings
See the #1 stock for the next 7 days that we like better than CLNE
CLNE Financial Statistics
Sales & Book Value
Annual Sales: | $425.16M |
---|---|
Cash Flow: | $1.38M |
Price / Cash Flow: | 0 |
Annual Sales: | $3.24 |
Price / Book: | 0.87 |
Profitability
EPS (TTM): | -0.35000 |
---|---|
Net Income (TTM): | $-79.24M |
Gross Margin: | $35.87M |
Return on Equity: | -11.04% |
Return on Assets: | -6.77% |
Clean Energy Fuels Earnings Forecast
Key Clean Energy Fuels Financial Ratios
- The Gross Profit Margin over the past 21 years for CLNE is 8.44%.
- The Selling, General & Administrative Expenses for CLNE have been equal to 26.41% of Gross Profit Margin.
- The Research & Development expenses have been 0.00% of Revenue.
- The Interest Expense is -23.04% of Operating Income.
- The Net Earning history of CLNE is -23.40% of Total Revenues.
- Per Share Earnings over the last 21 years have been positive in 10 years.
Clean Energy Fuels Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Oil, Gas & Consumable Fuels |
Sector: | Energy |
Current Symbol: | CLNE |
CUSIP: | 184499 |
Website: | cleanenergyfuels.com |
Debt
Debt-to-Equity Ratio: | 0.36 |
---|---|
Current Ratio: | 3.17 |
Quick Ratio: | 2.57 |
Price-to-Earnings
Trailing P/E Ratio: | 0 |
---|---|
Forward P/E Ratio: | 0 |
CLNE Technical Analysis vs Fundamental Analysis
Sell
41
Clean Energy Fuels (CLNE)
is a Sell
Is Clean Energy Fuels a Buy or a Sell?
-
Clean Energy Fuels stock is rated a Sell
The current Clean Energy Fuels [CLNE] share price is $2.83. The Score for CLNE is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.